An Open-label Single-arm Prospective Study of Continuous Intervention with Designated Treatment Application for NASH (Non-Alcoholic Steatohepatitis) Patients

An Open-label Single-arm Prospective Study of Continuous Intervention with Designated Treatment Application for NASH (Non-Alcoholic Steatohepatitis) Patients - A study of NASH treatment application for patients with non alcoholic steatohepatitis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029835

Enrollment

Registered

2017-12-31

Start date

2018-02-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic steatohepatitis

Interventions

Treatment aid for non-alcoholic steatohepatitis application

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with histologically diagnosed non-alcoholic who agree to participate in the study after enough explanation about the study.

Exclusion criteria

Exclusion criteria: 1.patients do not agree 2.patients who are regarded as difficult to use a smartphone 3.patients with viral hepatitis 4.patients diagnosed as autoimmune hepatitis 5.patients diagnosed as metabolic disease 6.patients who are histologically diagnosed as cirrhosis 7.patients with current or history of hepatocellular carcinoma 8.patients with condition that cannot be performed liver biopsy safely

Design outcomes

Primary

Measure	Time frame
Histological improvement of non-alcoholic steatohepatitis following 1 year therapeutic treatment with application	—

Countries

Japan

Contacts

Public ContactMasaya Sato

The University of Tokyo Hospital Department of Clinical Laboratory Medicine (Department of Gastroenterology)

masayasato0407@gmail.com0338155411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026